These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35349196)

  • 21. Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.
    Szabo A; Kovacs A; Frecska E; Rajnavolgyi E
    PLoS One; 2014; 9(8):e106533. PubMed ID: 25171370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    Blair JB; Kurrasch-Orbaugh D; Marona-Lewicka D; Cumbay MG; Watts VJ; Barker EL; Nichols DE
    J Med Chem; 2000 Nov; 43(24):4701-10. PubMed ID: 11101361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT(1A) and 5-HT(2A) receptors.
    Riga MS; Bortolozzi A; Campa L; Artigas F; Celada P
    Neuropharmacology; 2016 Feb; 101():370-8. PubMed ID: 26477571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
    Commissaris RL; Davis M
    Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.
    Wallach JV
    Med Hypotheses; 2009 Jan; 72(1):91-4. PubMed ID: 18805646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)].
    Dittrich A; Bickel P; Schöpf J; Zimmer D
    Arch Psychiatr Nervenkr (1970); 1976 Dec; 223(1):77-87. PubMed ID: 1070948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.
    Cameron LP; Patel SD; Vargas MV; Barragan EV; Saeger HN; Warren HT; Chow WL; Gray JA; Olson DE
    ACS Chem Neurosci; 2023 Feb; 14(3):351-358. PubMed ID: 36630260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor.
    Preller KH; Burt JB; Ji JL; Schleifer CH; Adkinson BD; Stämpfli P; Seifritz E; Repovs G; Krystal JH; Murray JD; Vollenweider FX; Anticevic A
    Elife; 2018 Oct; 7():. PubMed ID: 30355445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DMT alters cortical travelling waves.
    Alamia A; Timmermann C; Nutt DJ; VanRullen R; Carhart-Harris RL
    Elife; 2020 Oct; 9():. PubMed ID: 33043883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.
    Barker SA
    Psychopharmacology (Berl); 2022 Jun; 239(6):1749-1763. PubMed ID: 35064294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-
    Glatfelter GC; Naeem M; Pham DNK; Golen JA; Chadeayne AR; Manke DR; Baumann MH
    ACS Pharmacol Transl Sci; 2023 Apr; 6(4):567-577. PubMed ID: 37082754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.
    Tap SC
    Addict Biol; 2024 Apr; 29(4):e13386. PubMed ID: 38600715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate.
    Jiménez JH; Bouso JC
    J Psychopharmacol; 2022 Aug; 36(8):905-919. PubMed ID: 35695604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT).
    Reckweg JT; Uthaug MV; Szabo A; Davis AK; Lancelotta R; Mason NL; Ramaekers JG
    J Neurochem; 2022 Jul; 162(1):128-146. PubMed ID: 35149998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When the endogenous hallucinogenic trace amine N,N-dimethyltryptamine meets the sigma-1 receptor.
    Su TP; Hayashi T; Vaupel DB
    Sci Signal; 2009 Mar; 2(61):pe12. PubMed ID: 19278957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.
    Jiang XL; Shen HW; Yu AM
    Neuropharmacology; 2015 Feb; 89():342-51. PubMed ID: 25446678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of psychedelic tryptamine derivatives with a lipid bilayer.
    Zohairi F; Khandelia H; Hakami Zanjani AA
    Chem Phys Lipids; 2023 Mar; 251():105279. PubMed ID: 36627076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
    Riba J; McIlhenny EH; Bouso JC; Barker SA
    Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.